Fourteen-day triple therapy with a proton pump inhibitor (PPI) plus clarithromycin and either amoxicillin or metronidazole is superior to 7-day therapy in eradicating Heliobacter pylori (strength of recommendation [SOR]: A, highquality meta-analysis). Seven-day triple therapy with a PPI or ranitidine bismuth citrate plus clarithromycin and either amoxicillin or metronidazole is also effective (SOR: A, high-quality systematic review). Three-day quadruple therapy with a combination of PPI, clarithromycin, bismuth subcitrate, and metronidazole or a combination of PPI, clarithromycin, amoxicillin, and metronidazole also appears to be effective (SOR: B, unblinded randomized controlled trial)
none61siBACKGROUND: Helicobacter pylori is associated with benign and malignant diseases of the uppe...
Abstract: Background: It has been suggested that short-term triple therapy comprising a proton pump ...
H. pylori infection remains a worldwide spread disease with a definite morbidity and mortality. Unfo...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
Background: Traditional standard triple therapy for Helicobacter pylori (H. pylori) infection (proto...
Th e most popular regimen for eradication of Helicobacter pylori (H. pylori) infection is triple the...
none6noBackground and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple t...
Background and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple therapie...
INTRODUCTION: Helicobacter pylori resistance to antibiotics is steadily increasing and multidrug-re...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
Background and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple therapie...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
none61siBACKGROUND: Helicobacter pylori is associated with benign and malignant diseases of the uppe...
Abstract: Background: It has been suggested that short-term triple therapy comprising a proton pump ...
H. pylori infection remains a worldwide spread disease with a definite morbidity and mortality. Unfo...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
The treatment of Helicobacter pylori infection includes of current standard triple therapies consist...
Background: Traditional standard triple therapy for Helicobacter pylori (H. pylori) infection (proto...
Th e most popular regimen for eradication of Helicobacter pylori (H. pylori) infection is triple the...
none6noBackground and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple t...
Background and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple therapie...
INTRODUCTION: Helicobacter pylori resistance to antibiotics is steadily increasing and multidrug-re...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
Background and aims Italian guideline suggests 10-day sequential or bismuth-based quadruple therapie...
Standard triple therapies are the most used treatment in the clinical practice. However, a critical ...
none61siBACKGROUND: Helicobacter pylori is associated with benign and malignant diseases of the uppe...
Abstract: Background: It has been suggested that short-term triple therapy comprising a proton pump ...
H. pylori infection remains a worldwide spread disease with a definite morbidity and mortality. Unfo...